Multiple Sclerosis, Relapsing-Remitting
Item
1. subject with a relapsing form of ms; diagnosis of ms is in accordance with the mcdonald criteria
boolean
C0751967 (UMLS CUI [1])
Rebif
Item
2. subject currently taking rebif 44mcg tiw, and has been on this treatment for at least 6 months (24 weeks) prior to study enrollment
boolean
C0752980 (UMLS CUI [1])
REBIJECT II | Needle Gauge
Item
3. subject currently using rebiject ii and 29 gauge needle
boolean
C3473277 (UMLS CUI [1])
C3640175 (UMLS CUI [2])
Age
Item
4. subject is between 18 and 60 years old inclusive
boolean
C0001779 (UMLS CUI [1])
Able to read English Language | Comprehension English Language
Item
5. subject is able to read and understand english
boolean
C0586740 (UMLS CUI [1,1])
C0376245 (UMLS CUI [1,2])
C0233733 (UMLS CUI [2,1])
C0376245 (UMLS CUI [2,2])
Protocol Compliance
Item
6. subject is willing to follow study procedures
boolean
C0525058 (UMLS CUI [1])
Informed Consent
Item
7. subject has given written informed consent and signed hipaa
boolean
C0021430 (UMLS CUI [1])
Gender | Pregnancy Absent | Breast Feeding Absent | Childbearing Potential Lacking | Postmenopausal state | Female Sterilization | Hormonal contraception | Intrauterine Devices | Vaginal contraceptive diaphragm | Vaginal Spermicides | Female Condoms
Item
8. female subjects must not be either pregnant or breast-feeding and must lack childbearing potential, as defined by either: i) being post-menopausal or surgically sterile, or ii) using a hormonal contraceptive, intra-uterine device, diaphragm with spermicide, or condom with spermicide, for the duration of the study. (confirmation required within 30 days prior to start of the study)
boolean
C0079399 (UMLS CUI [1])
C0032961 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C0006147 (UMLS CUI [3,1])
C0332197 (UMLS CUI [3,2])
C3831118 (UMLS CUI [4,1])
C0332268 (UMLS CUI [4,2])
C0232970 (UMLS CUI [5])
C0015787 (UMLS CUI [6])
C2985296 (UMLS CUI [7])
C0021900 (UMLS CUI [8])
C0042241 (UMLS CUI [9])
C0087145 (UMLS CUI [10])
C0221829 (UMLS CUI [11])
Injectables | Influenza vaccination Acceptable | Pneumococcal immunisation Acceptable
Item
1. use of any other injectable medications on a regular basis during the week prior to the screening period or during the screening or treatment periods. receiving a single injection for treatment or prophylaxis of a condition unrelated to the subject's multiple sclerosis or the subject's rebif® therapy (e.g., receiving a influenza or pneumococcus vaccination) is acceptable
boolean
C0086466 (UMLS CUI [1])
C0042200 (UMLS CUI [2,1])
C1879533 (UMLS CUI [2,2])
C2082604 (UMLS CUI [3,1])
C1879533 (UMLS CUI [3,2])
Combined Modality Therapy Multiple Sclerosis | Rebif
Item
2. subject receiving ms therapy in addition (i.e., combination therapy) to rebif® within 3 months prior to study enrollment or at any time during study protocol.
boolean
C0009429 (UMLS CUI [1,1])
C0026769 (UMLS CUI [1,2])
C0752980 (UMLS CUI [2])
Rebif Formulation New
Item
3. subjects who have previously been on rebif new formulation (rnf).
boolean
C0752980 (UMLS CUI [1,1])
C0524527 (UMLS CUI [1,2])
C0205314 (UMLS CUI [1,3])
Progressive multiple sclerosis
Item
4. subject with progressive forms of multiple sclerosis (ms).
boolean
C0393665 (UMLS CUI [1])
Chronic pain syndrome
Item
5. subject with history of any chronic pain syndrome.
boolean
C1298685 (UMLS CUI [1])
Disease Explanation Signs and Symptoms
Item
6. subject has any other disease apart from ms that could better explain the subjects signs and symptoms.
boolean
C0012634 (UMLS CUI [1,1])
C0681841 (UMLS CUI [1,2])
C0037088 (UMLS CUI [1,3])
Complete Transverse Myelitis | Bilateral optic neuritis
Item
7. subject has complete transverse myelitis or bilateral optic neuritis.
boolean
C0026976 (UMLS CUI [1,1])
C0205197 (UMLS CUI [1,2])
C0861152 (UMLS CUI [2])
Investigational New Drugs | Therapy, Investigational
Item
8. subjects that use any investigational drug or experimental procedure within 12 weeks of visit 1.
boolean
C0013230 (UMLS CUI [1])
C0949266 (UMLS CUI [2])
Adrenal Cortex Hormones Oral | CORTICOSTEROIDS FOR SYSTEMIC USE | Corticotropin
Item
9. subject received oral or systemic corticosteroids or acth within 30 days of visit 1 (prior to enrollment).
boolean
C0001617 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C3653708 (UMLS CUI [2])
C0001655 (UMLS CUI [3])
Liver Dysfunction | Elevated total bilirubin | Aspartate aminotransferase increased | Alanine aminotransferase increased | Alkaline phosphatase raised
Item
10. subject has inadequate liver function, defined by a total bilirubin, aspartate aminotransferase (ast) or alanine aminotransferase (alt) or alkaline phosphatase > 2.5 times the upper limit of the normal values.
boolean
C0086565 (UMLS CUI [1])
C0741494 (UMLS CUI [2])
C0151904 (UMLS CUI [3])
C0151905 (UMLS CUI [4])
C0151849 (UMLS CUI [5])
Few mature neutrophils in the bone marrow | White blood cell count decreased
Item
11. subject has inadequate bone marrow reserve, defined as a white blood cell count less than 0.5 x lower limit of normal.
boolean
C2748959 (UMLS CUI [1])
C0750394 (UMLS CUI [2])
Autoimmune Diseases
Item
12. subject suffers from other current autoimmune disease.
boolean
C0004364 (UMLS CUI [1])
Illness Major At risk Patient | Mental disorders Major At risk Patient | Illness Major Affecting Protocol Compliance | Mental disorders Major Affecting Protocol Compliance
Item
13. subject suffers from major medical or psychiatric illness that in the opinion of the investigator creates undue risk to the subject or could affect compliance with the study protocol
boolean
C0221423 (UMLS CUI [1,1])
C0205164 (UMLS CUI [1,2])
C1444641 (UMLS CUI [1,3])
C0030705 (UMLS CUI [1,4])
C0004936 (UMLS CUI [2,1])
C0205164 (UMLS CUI [2,2])
C1444641 (UMLS CUI [2,3])
C0030705 (UMLS CUI [2,4])
C0221423 (UMLS CUI [3,1])
C0205164 (UMLS CUI [3,2])
C0392760 (UMLS CUI [3,3])
C0525058 (UMLS CUI [3,4])
C0004936 (UMLS CUI [4,1])
C0205164 (UMLS CUI [4,2])
C0392760 (UMLS CUI [4,3])
C0525058 (UMLS CUI [4,4])
Pregnancy | Pregnancy, Planned
Item
14. subject is pregnant or attempting to conceive
boolean
C0032961 (UMLS CUI [1])
C0032992 (UMLS CUI [2])
Visual Impairment Excludes Subject Diary Completion | Physical impairment Excludes Subject Diary Completion | Visual Impairment Excludes Questionnaires Completion | Physical impairment Excludes Questionnaires Completion
Item
15. visual or physical impairment that precludes completion of diaries and questionnaires.
boolean
C3665347 (UMLS CUI [1,1])
C0332196 (UMLS CUI [1,2])
C3890583 (UMLS CUI [1,3])
C0205197 (UMLS CUI [1,4])
C0231171 (UMLS CUI [2,1])
C0332196 (UMLS CUI [2,2])
C3890583 (UMLS CUI [2,3])
C0205197 (UMLS CUI [2,4])
C3665347 (UMLS CUI [3,1])
C0332196 (UMLS CUI [3,2])
C0034394 (UMLS CUI [3,3])
C0205197 (UMLS CUI [3,4])
C0231171 (UMLS CUI [4,1])
C0332196 (UMLS CUI [4,2])
C0034394 (UMLS CUI [4,3])
C0205197 (UMLS CUI [4,4])